Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Manabu Kishina
Patient With Drug-Induced Hepatic Injury Caused by Long-Term Administration of an Angiotesin II Receptor Antagonist, Losartan
Acta Hepatologica Japonica
Hepatology
Related publications
Long-Term Effects of Angiotensin II Receptor Antagonist Losartan on Uric Acid Metabolism in Hyperuricemic Patients
Gout and Nucleic Acid Metabolism
Long-Term Consequences of Fetal Angiotensin II Receptor Antagonist Exposure
Case Reports in Pediatrics
Losartan Prevents Heart Fibrosis Induced by Long-Term Intensive Exercise in an Animal Model
PLoS ONE
Multidisciplinary
Losartan Treating Podocyte Injury Induced by Ang II via Downregulation of TRPC6 in Podocytes
JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal Medicine
Endocrinology
Reduction of Bleomycin Induced Lung Fibrosis by Candesartan Cilexetil, an Angiotensin II Type 1 Receptor Antagonist
Thorax
Pulmonary
Respiratory Medicine
Internalization of Constitutively Active N111G Mutant of AT1 Receptor Induced by Angiotensin II–Receptor Antagonists Candesartan, Losartan, and Telmisartan: Comparison With Valsartan
Journal of Pharmacological Sciences
Molecular Medicine
Pharmacology
Motor Neuron Involvement in a Patient With Long-Term Corticosteroid Administration
Internal Medicine
Internal Medicine
Medicine
P33: Antenatal Administration of a Potential Interleukin‐6 Receptor Antagonist Prevents Inflammation‐induced Preterm Birth and Fetal Tissue Injury
American Journal of Reproductive Immunology
Gynecology
Reproductive Medicine
Immunology
Obstetrics
Allergy
Effect of the Angiotensin II Receptor Antagonist Losartan on Uric Acid and Oxypurine Metabolism in Healthy Subjects.
Internal Medicine
Internal Medicine
Medicine